1. Home
  2. WDS vs DGX Comparison

WDS vs DGX Comparison

Compare WDS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Woodside Energy Group Limited

WDS

Woodside Energy Group Limited

HOLD

Current Price

$16.61

Market Cap

33.0B

Sector

Energy

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$182.89

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDS
DGX
Founded
1954
1967
Country
Australia
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.0B
20.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
WDS
DGX
Price
$16.61
$182.89
Analyst Decision
Hold
Buy
Analyst Count
1
15
Target Price
N/A
$194.07
AVG Volume (30 Days)
638.8K
1.2M
Earning Date
08-18-2025
10-21-2025
Dividend Yield
6.15%
1.75%
EPS Growth
58.72
14.49
EPS
1.54
8.51
Revenue
$13,781,000,000.00
$10,850,000,000.00
Revenue This Year
N/A
$12.37
Revenue Next Year
N/A
$3.52
P/E Ratio
$10.74
$21.44
Revenue Growth
9.53
13.74
52 Week Low
$11.26
$148.70
52 Week High
$17.70
$197.55

Technical Indicators

Market Signals
Indicator
WDS
DGX
Relative Strength Index (RSI) 51.23 44.87
Support Level $16.21 $184.18
Resistance Level $16.98 $185.12
Average True Range (ATR) 0.24 3.22
MACD -0.05 -0.78
Stochastic Oscillator 38.77 3.85

Price Performance

Historical Comparison
WDS
DGX

About WDS Woodside Energy Group Limited

Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: